Breast Cancers Today Videos

Advertisement
Antonio Llombart Cussac, MD, PhDHR Breast Cancer | May 14, 2025
PALMIRA trial shows limited benefit of palbociclib rechallenge in HR+/HER2- breast cancer, guiding future treatment choices.
View More
David Winchester, MDBreast Cancer News | May 10, 2025
New staging model links treatment response to survival, refining breast cancer prognosis after neoadjuvant chemotherapy.
David Winchester, MDBreast Cancer News | May 5, 2025
A new AJCC model refines breast cancer staging after neoadjuvant chemo, filling a key gap in patient prognostication.
Hatem Soliman, MDHER2 Breast Cancer | April 29, 2025
Dr. Soliman explores dendritic cell vaccines to boost immunity and cut chemo toxicity in early HER2-positive breast cancer.
Hatem Soliman, MDHER2 Breast Cancer | April 29, 2025
Pilot study shows HER2-targeted dendritic cell vaccines may enhance immune response in early HER2-positive breast cancer.
Sara Nunnery, MD, MSCIHER2 Breast Cancer | May 1, 2025
Dr. Nunnery weighs IV Enhertu vs oral chemo, highlighting how patient goals and QoL shape treatment decisions.
Sara Nunnery, MD, MSCIHER2 Breast Cancer | May 6, 2025
Dr. Nunnery discusses HER2-low and ultralow testing and Enhertu’s role after DESTINY-Breast06 in metastatic breast cancer.
Dr. Sadie Dobrozsi, EvolentGenetics & Breast Cancer | March 26, 2025
Dr. Sadie Dobrozsi spoke on the importance of genetic testing in breast cancer to better understand the disease.
Leah Pyter, PhDBreast Cancer News | March 26, 2025
Dr. Leah Pyter details a study which found that chemotherapy induces microbiome disruption and inflammation in BC patients.
Dr. Mik RinneHR Breast Cancer | July 19, 2024
Dr. Mik Rinne discusses a study on the efficacy of the CDK2 inhibitor BLU-222 in patients with HR+/HER2- breast cancer.
Carlos Doti, MDBreast Cancer News | March 26, 2025
Carlos Doti, MD, of AstraZeneca, discusses the impact of LYNPARZA over the last decade.
Nera Lopetegui-Lia, MDHER2 Breast Cancer | March 31, 2025
Dr. Lopetegui-Lia reacts to Dr. Gatti-Mays' breast cancer panel discussion from Advancements in Oncology.
Dr. Margaret Gatti-MaysAdvancements in Oncology | June 13, 2024
Dr. Margaret Gatti-Mays explains what makes The Oncology Brothers' content so important for community oncologists.
Dr. Margaret Gatti-MaysBreast Cancer News | March 26, 2025
Dr. Margaret Gatti-Mays explains how to address the most pressing questions in triple-negative breast cancer treatments.
Dr. Margaret Gatti-MaysTriple-Negative Breast Cancer | March 26, 2025
Dr. Gatti-Mays discusses how treatment for triple-negative breast cancer has evolved in recent years.
Dr. Margaret Gatti-MaysHER2 Breast Cancer | March 31, 2025
Dr. Margaret Gatti-Mays delves into the topic of HER2 tumor expression in breast cancer.
Dr. Eric VachonBreast Cancer News | March 26, 2025
A study examined the impact of relationship satisfaction and agreement between breast cancer survivors and their partners.
Dr. Margaret Gatti-MaysBreast Cancer News | March 26, 2025
Dr. Gatti-Mays talks about the importance of tailoring treatments to individual patients with breast cancer.
Dr. Barbara SmithBreast Cancer News | March 26, 2025
Barbara Smith, MD, PhD, discusses the Lumicell Direct Visualization System and how it can enhance breast cancer detection.
Dr. Timothy YapHER2 Breast Cancer | March 26, 2025
Dr. Timothy Yap discusses the PETRA trial, which showed the efficacy of saruparib in treating HER2-negative breast cancer.
Advertisement
Advertisement
Latest News

May 15, 2025